AAAAAA

   
Results: 1-21 |
Results: 21
SAFETY AND EFFICACY OF OXCARBAZEPINE MONOTHERAPY
Authors: SACHDEO R BEYDOUN A SCHACHTER S VAZQUEZ B SCHAUL N MESENBRINK P DSOUZA J
Citation: R. Sachdeo et al., SAFETY AND EFFICACY OF OXCARBAZEPINE MONOTHERAPY, Neurology, 50(4), 1998, pp. 4005-4005
COMPARISON OF URINE TOTAL PROTEIN ASSAYS
Authors: HOHNADEL D LACAGNINA P SCALES M ROWLAND S DSOUZA J
Citation: D. Hohnadel et al., COMPARISON OF URINE TOTAL PROTEIN ASSAYS, Clinical chemistry, 44, 1998, pp. 74-74
CORE LAB CONCEPTION TO CORE LAB OPERATION
Authors: OVERBAGH B HOHNADEL D ROWLAND S DSOUZA J
Citation: B. Overbagh et al., CORE LAB CONCEPTION TO CORE LAB OPERATION, Clinical chemistry, 44, 1998, pp. 241-241
ALTERNATIVE SAMPLES FOR TROPONIN-I TESTING
Authors: HOHNADEL D FESS J SCALES M ROWLAND S DSOUZA J
Citation: D. Hohnadel et al., ALTERNATIVE SAMPLES FOR TROPONIN-I TESTING, Clinical chemistry, 44, 1998, pp. 522-522
HIGH-RISK CORNEAL TRANSPLANTS (CTX) - ANALYSIS OF VARIABLES ASSOCIATED WITH OUTCOME
Authors: WOLLENZIEN J WOLLENZIEN T DSOUZA J BROWN J GOEKEN N
Citation: J. Wollenzien et al., HIGH-RISK CORNEAL TRANSPLANTS (CTX) - ANALYSIS OF VARIABLES ASSOCIATED WITH OUTCOME, Human immunology, 55, 1997, pp. 134-134
EXPECTED RANGE VALIDATION FOR AST(VIS), ALT, ALK PHOS, CK, GGT, LD METHODS
Authors: HOHNADEL D ROWLAND S COPPOLA J DSOUZA J
Citation: D. Hohnadel et al., EXPECTED RANGE VALIDATION FOR AST(VIS), ALT, ALK PHOS, CK, GGT, LD METHODS, Clinical chemistry, 43, 1997, pp. 81-81
IMPLEMENTING ROBOTIC SAMPLING IN HIGH-VOLUME TESTS REQUIRING PRETREATMENT
Authors: VANVESSEM T HOHNADEL D OVERBAGH B ROWLAND S DSOUZA J
Citation: T. Vanvessem et al., IMPLEMENTING ROBOTIC SAMPLING IN HIGH-VOLUME TESTS REQUIRING PRETREATMENT, Clinical chemistry, 43, 1997, pp. 114-114
ANALYTICAL EVALUATION OF OSTEX(TM) N-TELEOPEPTIDE (NTX) ASSAY FOR ROUTINE LABORATORY USE
Authors: HOHNADEL D MURRAY C MANCARI SD ROWLAND S FRICKE W DSOUZA J
Citation: D. Hohnadel et al., ANALYTICAL EVALUATION OF OSTEX(TM) N-TELEOPEPTIDE (NTX) ASSAY FOR ROUTINE LABORATORY USE, Clinical chemistry, 42(6), 1996, pp. 278-278
GRAPHICAL EVALUATION METHOD FOR PROFICIENCY TEST SAMPLES
Authors: XANDER S HOHNADEL D MANCARI SD ROWLAND S FRICKE W DSOUZA J
Citation: S. Xander et al., GRAPHICAL EVALUATION METHOD FOR PROFICIENCY TEST SAMPLES, Clinical chemistry, 42(6), 1996, pp. 747-747
ON NEW NONNATIVE ENGLISHES - A QUARTET
Authors: SINGH R DSOUZA J MOHANAN KP PRABHU NS
Citation: R. Singh et al., ON NEW NONNATIVE ENGLISHES - A QUARTET, Journal of pragmatics, 24(3), 1995, pp. 283-294
COMPARISON OF SIGMA DIRECT LDL-C AND THE CALCULATED LDL-C
Authors: HOHNADEL DC VANVESSEM T ROWLAND S DSOUZA J
Citation: Dc. Hohnadel et al., COMPARISON OF SIGMA DIRECT LDL-C AND THE CALCULATED LDL-C, Clinical chemistry, 41(6), 1995, pp. 198-198
POINT OF CARE PHLEBOTOMIST REDUCES LABORATORY TURN AROUND TIMES FOR EMERGENCY DEPARTMENT
Authors: OVERBAGH B QUATTLANDER D ROWLAND S HOHNADEL D DSOUZA J METZ D SHAMASKIN A
Citation: B. Overbagh et al., POINT OF CARE PHLEBOTOMIST REDUCES LABORATORY TURN AROUND TIMES FOR EMERGENCY DEPARTMENT, Clinical chemistry, 41(6), 1995, pp. 209-209
THE COST AND EFFECTIVENESS OF SCREENING SAMPLES FOR CK MB ISOENZYMES ON THE KODAK (JOHNSON AND JOHNSON) EKTACHEM(R)-700 AND CONFIRMING POSITIVES ON THE ABBOTT IM(X)(R)
Authors: COPPOLA J HOHNADEL D MANCARI D DSOUZA J
Citation: J. Coppola et al., THE COST AND EFFECTIVENESS OF SCREENING SAMPLES FOR CK MB ISOENZYMES ON THE KODAK (JOHNSON AND JOHNSON) EKTACHEM(R)-700 AND CONFIRMING POSITIVES ON THE ABBOTT IM(X)(R), Clinical chemistry, 41(6), 1995, pp. 236-236
CLINICAL-TRIALS IN COGNITIVELY IMPAIRED OLDER ADULTS - HOME VERSUS CLINIC ASSESSMENTS
Authors: BEDARD M MOLLOY DW STANDISH T GUYATT GH DSOUZA J MONDADORI C DARZINS PJ
Citation: M. Bedard et al., CLINICAL-TRIALS IN COGNITIVELY IMPAIRED OLDER ADULTS - HOME VERSUS CLINIC ASSESSMENTS, Journal of the American Geriatrics Society, 43(10), 1995, pp. 1127-1130
CORRELATIONS OF PLASMA AND URINARY PHENYLACETIC ACID AND PHENYLETHYLAMINE CONCENTRATIONS WITH EATING BEHAVIOR AND MOOD RATING SCORES IN BROFAROMINE-TREATED WOMEN WITH BULIMIA-NERVOSA
Authors: DAVIS BA KENNEDY SH DSOUZA J DURDEN DA GOLDBLOOM DS BOULTON AA
Citation: Ba. Davis et al., CORRELATIONS OF PLASMA AND URINARY PHENYLACETIC ACID AND PHENYLETHYLAMINE CONCENTRATIONS WITH EATING BEHAVIOR AND MOOD RATING SCORES IN BROFAROMINE-TREATED WOMEN WITH BULIMIA-NERVOSA, Journal of psychiatry & neuroscience, 19(4), 1994, pp. 282-288
A CANADIAN MULTICENTER PLACEBO-CONTROLLED STUDY OF A FIXED-DOSE OF BROFAROMINE, A REVERSIBLE SELECTIVE MAO-A INHIBITOR, IN THE TREATMENT OFMAJOR DEPRESSION
Authors: CHOUINARD G SAXENA BM NAIR NPV KUTCHER SP BAKISH D BRADWEJN J KENNEDY SH SHARMA V REMICK RA KUKHAMOHAMAD SA BELANGER MC SNAITH J BEAUCLAIR L POHLMANN H DSOUZA J
Citation: G. Chouinard et al., A CANADIAN MULTICENTER PLACEBO-CONTROLLED STUDY OF A FIXED-DOSE OF BROFAROMINE, A REVERSIBLE SELECTIVE MAO-A INHIBITOR, IN THE TREATMENT OFMAJOR DEPRESSION, Journal of affective disorders, 32(2), 1994, pp. 105-114
EFFECT OF A NEW NOOTROPIC AGENT, CGS-5649B, ON COGNITION, FUNCTION, AND BEHAVIOR IN DEMENTIA
Authors: MOLLOY DW GUYATT GH STANDISH T WILLAN A MCILROY W DSOUZA J BROWN G MONDADORI C
Citation: Dw. Molloy et al., EFFECT OF A NEW NOOTROPIC AGENT, CGS-5649B, ON COGNITION, FUNCTION, AND BEHAVIOR IN DEMENTIA, Journal of general internal medicine, 8(8), 1993, pp. 444-447
EFFECTS OF CHRONIC BROFAROMINE ADMINISTRATION ON BIOGENIC-AMINES INCLUDING SULPHATOXYMELATONIN AND ACID METABOLITES IN PATIENTS WITH BULIMIA-NERVOSA
Authors: KENNEDY SH DAVIS BA BROWN GM FORD CG DSOUZA J
Citation: Sh. Kennedy et al., EFFECTS OF CHRONIC BROFAROMINE ADMINISTRATION ON BIOGENIC-AMINES INCLUDING SULPHATOXYMELATONIN AND ACID METABOLITES IN PATIENTS WITH BULIMIA-NERVOSA, Neurochemical research, 18(12), 1993, pp. 1281-1285
BROFAROMINE IN DEPRESSION - A CANADIAN MULTICENTER PLACEBO TRIAL AND A REVIEW OF STANDARD DRUG COMPARATIVE-STUDIES
Authors: CHOUINARD G SAXENA BM NAIR NPV KUTCHER SP BAKISH D BRADWEJN J KENNEDY SH SHARMA V REMICK RA KUKHAMOHAMAD SA BEAUCLAIR L SNAITH J DSOUZA J
Citation: G. Chouinard et al., BROFAROMINE IN DEPRESSION - A CANADIAN MULTICENTER PLACEBO TRIAL AND A REVIEW OF STANDARD DRUG COMPARATIVE-STUDIES, Clinical neuropharmacology, 16, 1993, pp. 190000051-190000054
REVERSIBLE MONOAMINE OXIDASE-A INHIBITORS IN PANIC DISORDER
Authors: BAKISH D SAXENA BM BOWEN R DSOUZA J
Citation: D. Bakish et al., REVERSIBLE MONOAMINE OXIDASE-A INHIBITORS IN PANIC DISORDER, Clinical neuropharmacology, 16, 1993, pp. 190000077-190000082
THE EFFECT OF THE MAO-A SELECTIVE INHIBITOR BROFAROMINE ON THE PLASMAAND URINE CONCENTRATIONS OF SOME BIOGENIC-AMINES AND THEIR ACIDIC METABOLITES IN BULIMIA-NERVOSA
Authors: DAVIS BA KENNEDY SH DURDEN DA DSOUZA J GOLDBLOOM DS BOULTON AA
Citation: Ba. Davis et al., THE EFFECT OF THE MAO-A SELECTIVE INHIBITOR BROFAROMINE ON THE PLASMAAND URINE CONCENTRATIONS OF SOME BIOGENIC-AMINES AND THEIR ACIDIC METABOLITES IN BULIMIA-NERVOSA, Progress in neuro-psychopharmacology & biological psychiatry, 17(5), 1993, pp. 747-763
Risultati: 1-21 |